Systemic options other than chemo: Combination trials and 3rd generation TKIs
系统化的观点 超过 化疗 ,联合治疗和三代的 TKI药物
3rd generation TKIs: CO1686, AZD9291, HM61713, EGFR816, ASP8273: Look promising, but most requires repeat biopsy (more on this in next talk from Dr. Sequist). More on 3rd gen TKI from Dr. Pasi Janne in afternoon breakout session
这些药不用我翻译吧 9291 1686
Combination trials: Afatinib/cetuximab farthest along; AUY922/erlotinib, MET inhibitor/EGFR TKI, others. More on combo trials from Dr. Melissa Johnson at afternoon breakout session)
AUY922 (NVP-AUY922)是一种高效的HSP90抑制剂,其对HSP90α/β的IC50为13 nM
Other trials: Any active agent can be considered including immunotherapy.
Kick the can down the road 抛开问题
Local ablation消融 切除 of spots that are growing then restart TKI
Chemo + TKI 化疗和TKI
Chemo alone (but, must start quickly after stopping TKI and reconsider TKI later)化疗
Combination Therapies 联合治疗
3rd Generation TKIs 三代TKI
Other clinical trials